International Journal of Cancer
@IntJCanc
Official journal of @UICC
Heidelberg/Germany -RT≠ endorsement
IF: 6.4 (2022)
Tweets by editorial office
#CancerResearch
17-03-2015 15:57:23
2,2K Tweets
1,7K Followers
1,3K Following
NOW ONLINE
This study assessed the efficacy/safety of everolimus+exemestane for the treatment of HR+, HER2-advanced #BreastCancer , evaluated patients' quality of life, management of stomatitis, and therapy sequence
➡️doi.org/10.1002/ijc.34…
